2008Modern Medicine HealthRequires access

Comparative study of schizophrenia treated with aripiprazole and risperidone

Tao Ling-gang

Open publisher page 0 citations

Abstract

Objective:To study the effect and adverse reaction between aripiprazole and risperidone in the treatment of schizophrenia.Methods:Aripiprazole and risperidone were used respectively to treat schizophrenia in each 34 cases,for 8 weeks.The positive and negative symptoms scale(PANSS) was used to evaluate the clinical effect,while the treatment emergent symptoms scale(TESS) was used to evaluate the adverse reaction.Results:There was significant difference in the total score of PANSS in both groups before and after treatment.The total effective rate was 82.3% in aripiprazole group,and identical to that in risperidone group of 82.3%(P0.05);while the incidenc rate of adverse reaction was 19.82% in aripiprazole group,lower than that in risperidone group of 25.32%,with significant difference between them(P0.05).Conclusion:The results suggested that aripirazole was as effective in the treatment of schizophrenia as risperidone.But aripiprazole was a safe and effective antipsychotic drug,with less adverse reaction.

About this research paper

What this paper is about

Objective:To study the effect and adverse reaction between aripiprazole and risperidone in the treatment of schizophrenia.Methods:Aripiprazole and risperidone were used respectively to treat schizophrenia in each 34 cases,for 8 weeks.The positive and negative symptoms scale(PANSS) was used to evaluate the clinical effect,while the treatment emergent symptoms scale(TESS) was used to evaluate the adverse reaction.Results:There was significant difference in the total score of PANSS in both groups before and after treatment.The total effective rate was 82.3% in aripiprazole group,and identical to that in risperidone group of 82.3%(P0.05);while the incidenc rate of adverse reaction was 19.82% in aripiprazole group,lower than that in risperidone group of 25.32%,with significant difference between them(P0.05).Conclusion:The results suggested that aripirazole was as effective in the treatment of schizophrenia as risperidone.But aripiprazole was a safe and effective antipsychotic drug,with less adverse reaction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the effect and adverse reaction between aripiprazole and risperidone in the treatment of schizophrenia.Methods:Aripiprazole and risperidone were used respectively to treat schizophrenia in each 34 cases,for 8 weeks.The positive and negative symptoms scale(PANSS) was used to evaluate the clinical effect,while the treatment emergent symptoms scale(TESS) was used to evaluate the adverse reaction.Results:There was significant difference in the total score of PANSS in both groups before and after treatment.The total effective rate was 82.3% in aripiprazole group,and identical to that in risperidone group of 82.3%(P0.05);while the incidenc rate of adverse reaction was 19.82% in aripiprazole group,lower than that in risperidone group of 25.32%,with significant difference between them(P0.05).Conclusion:The results suggested that aripirazole was as effective in the treatment of schizophrenia as risperidone.But aripiprazole was a safe and effective antipsychotic drug,with less adverse reaction.

Key concepts: Aripiprazole, Risperidone, Medicine, Schizophrenia (object-oriented programming), Adverse effect, Negative symptom, Positive and Negative Syndrome Scale, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study of schizophrenia treated with aripiprazole and risperidone — Research Paper | ScholarLens